Target intelligence / Profile preview

POLR2J3-UPK3BL2 readthrough (POLR2J3-UPK3BL2)

Target
POLR2J3-UPK3BL2
Molecular classification
Non-coding RNA, Long non-coding RNA (lncRNA)
01

Overview

POLR2J3-UPK3BL2 readthrough is a non-coding RNA transcript formed by a readthrough event between the adjacent genes POLR2J3 and UPK3BL2 on chromosome 7. It is classified as a long non-coding RNA (lncRNA) and is not predicted to code for a protein product. While its functional significance is not well-established, expression analyses link it to processes such as immune activation and neuro-retinal plasticity. There are no clinical drugs or biomarker roles attributed to this locus at present, and it is not considered a conventional druggable target.

02

Mechanism of action

Not applicable; as a lncRNA, no approved drugs are known to act on this molecule

03

Biological functions

Potential involvement in gene regulationLinked to immune activationLinked to neuro-retinal plasticity
04

Disease associations

None directly establishedSome associations with contexts such as neuro-retinal plasticity and immune function, but no clear disease link

Beyond the preview

Go deeper on POLR2J3-UPK3BL2 readthrough (POLR2J3-UPK3BL2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on POLR2J3-UPK3BL2 readthrough (POLR2J3-UPK3BL2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call